Hyperbaric Oxygen Therapy Devices Market to Expand at 7.20% CAGR to Reach US$2.98 bn by 2020

HBOT is a technique of delivering pure oxygen (100%) to the tissues under higher atmospheric pressures. Due to its ability to enhance the activities of the white blood cells at the wound site and block the cytotoxic effects of cyanide and carbon monoxide, HBOT is gaining wide acceptance across the globe. It has been studied that HBOT saturates the circulatory system of a patient with oxygen, which results in augmented oxygen delivery to the tissues that produce therapeutic effect in a patient’s body. HBOT is used for various medical indications such as necrotizing soft tissue infections, thermal burn injury, decompression sickness, etc. for which they have an FDA approval, however it has been observed that apart from the approved medical conditions HBOT is also used as a viable treatment for many off-label indications such as brain injuries and cancer. Thus, due to the high preference of hyperbaric oxygen therapy among physicians and patients the market of HBOT devices is expected to grow significantly in the near future, across the regions.

This 86 page report gives readers a comprehensive overview of the Hyperbaric Oxygen Therapy (HBOT) Devices Market. Browse through 9 data tables and 17 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/hbo-therapy-devices.html

On the basis of products, the report divides the global hyperbaric oxygen therapy devices market into monoplace HBOT devices, multiplace HBOT devices, and topical HBOT devices. In 2013, this market was led by monoplace HBOT devices, which generated more than US$900 mn at the time. Monoplace HBOT devices are highly sought after due to their high adoption rates coupled with high availability. Additionally, this segment is expected to show the fastest growth rate in the given forecast period, owing to the ease with which monoplace devices can be obtained and installed.

The report creates segments of the global hyperbaric oxygen therapy devices market, according to applications, as gas embolism, infection treatment, decompression sickness, wound healing, and others. Wound healing was the strongest segment in this market for 2013. The report’s authors say that this segment will continue leading the global hyperbaric oxygen therapy devices market for the given forecast period, as it is expanding at the fastest CAGR of 7.9% within it. This is attributed to the largely positive effects that HBOT can have on those suffering from wounds and injuries linked to diabetes.

The geographical analysis given in the report can be best understood through a segmented view, by dividing the global hyperbaric oxygen therapy devices market into the major parts of Asia Pacific, Europe, North America, and the Rest of the World. North America was the dominant region in 2013, owing to a high adoption of the therapy in wound treatment and other infections. On the other hand, the Asia Pacific region is expected to consistently display the fastest growth rate in this market for the given forecast period, owing to a high population density, a growing prevalence of medical complications of diabetes, and a rapidly developing healthcare infrastructure.

Get accurate market forecast and analysis on the Hyperbaric Oxygen Therapy (HBOT) Devices Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=806

The key players in the global hyperbaric oxygen therapy devices market, as stated in the report, are Hyperbaric SAC, Hearmec Co., Ltd., Haux-Life-Support GmbH, Gulf Coast Hyperbaric, Inc., Fink Engineering Pty Ltd., SOS Medical Group Ltd., IHC Hytech B.V., ETC Biomedical System, OxyHeal Health Group, and Sechrist Industries, Inc.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Hyperbaric Oxygen Therapy (HBOT) Devices Market Overview by Products and Applications 2020

Hyperbaric oxygen therapy (HBOT) is a procedure that is used to deliver pure oxygen under high atmospheric pressures to tissues in the human body. In HBOT devices, the atmospheric pressure is raised up to three times more in comparison with the normal pressure. When a tissue of the human body gets injured, it may need some more quantity of oxygen to heal properly. HBOT devices increase the amount of oxygen dissolved in the human body and improve the oxygen delivery to minimize injury and fight with infections.

Get Sample Report for more Professional Analysis on Hyperbaric Oxygen Therapy (HBOT) Devices at: http://bit.ly/2kvCr0o

The growing prevalence of chronic and acute wounds, rising incidence of wound site infections, and growing popularity of leisure and adventure activities are some of the major factors that are driving the global HBOT devices market. However, limited HBOT reimbursement coverage and the high cost of HBOT are the factors that are expected to hamper the growth of the market in the coming years.

According to a study presented by Transparency Market Research, in 2013, the global market for hyperbaric oxygen therapy devices was worth US$1.8 bn and is projected to reach a value of US$2.9 bn by the end of 2020. This market is estimated to exhibit a healthy 7.20% CAGR between 2014 and 2020.

Based on product type: The global HBOT devices market can be divided into topical, multiplace, and monoplace HBOT devices.

> In 2013, the monoplace HBOT devices segment dominated the global market and was valued at US$900 mn.

> The high growth rate of this segment can be attributed to several factors such as high commercial availability, high adoption rate, and accessibility of different types of monoplace chambers.

> Moreover, the monoplace oxygen devices segment is estimated to register the highest growth rate in the near future, owing to the easy device installation/set-up and procurement process, which will indirect fuel the growth of the global market.

Based on application: The global HBOT devices market can be segmented into gas embolism, wound healing, infection treatment, decompressing sickness, and others.

> In 2013, the wound healing segment held the largest share in the global HBOT devices market and is expected to remain in the leading position in the next few years.

> This segment is projected to exhibit a 7.90% CAGR between 2014 and 2020.

> The significant growth of the wound healing segment is due to the growing prevalence of chronic and acute wounds such as diabetic pressure ulcers and foot ulcers and the availability of effective therapeutics of HBOT in severe conditions.

Based on geography: The global HBOT devices market can be classified into North America, Europe, Asia Pacific, and Rest of the World.

> In 2013, the North America HBOT devices market led the overall market owing to the growing adoption of hyperbaric therapy and the presence of a large number of hyperbaric therapy centers in this region.

> In addition, constant technological advancements in this field and the increasing distribution network of international players are further augmenting the growth of the global HBOT devices market.
> In recent years, the Asia Pacific HBOT devices market has witnessed rapid growth due to the growing incidence of diabetes and related complications, including chronic wounds, diabetic foot ulcers, the improving healthcare infrastructure, and growing participation of international players in this market.

Read the Present Market Status of Hyperbaric Oxygen Therapy (HBOT) Devices at: http://www.transparencymarketresearch.com/hbo-therapy-devices.html

The prominent players operating in the global HBOT devices market include Sechrist Industries, Inc., ETC Biomedical System, Hearmec Co., Ltd., SOS Medical Group Ltd., OxyHeal Health Group, Fink Engineering Pty Ltd., Hyperbaric SAC., Haux-Life-Support GmbH, Gulf Coast Hyperbaric, Inc., and IHC Hytech B.V.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/